CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822082553
- Phone
- (781) 222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $654,036
- in 3 filings
Net −$654,036. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Hill Emily Luisa Chief Financial Officer | Grant or award | +26,665 | 109,995 | ||
| 2024-04-01 | Hill Emily Luisa Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2024-04-01 | SLATTERY JOSEPH P Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2024-04-01 | Weinand Dieter Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2024-04-01 | Sarchi Christopher Chief Commercial Officer | Grant or award | +22,225 | 94,470 | ||
| 2024-04-01 | Sarchi Christopher Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +66,675 | 66,675 | ||
| 2024-04-01 | Oliger Christy J. Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2024-04-01 | Levitsky Hyam Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2024-04-01 | Schwendenman Andrew Chief Accounting Officer | Grant or award | +17,775 | 40,536 | ||
| 2024-04-01 | Schwendenman Andrew Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +53,325 | 53,325 | ||
| 2023-11-16 | Xynos Konstantinos Chief Medical Officer | Sale | −7,313 | $10.92 | $80K | 112,714 |
| 2023-11-16 | Sarchi Christopher Chief Commercial Officer | Sale | −5,255 | $10.92 | $57K | 72,245 |
| 2023-09-18 | Hill Emily Luisa Chief Financial Officer | Grant or award | +83,330 | 83,330 | ||
| 2023-09-18 | Hill Emily Luisa Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-09-12 | Esposito Pamela Chief Business Officer | Option exercise 10b5-1 | +300 | $3.30 | $990 | 263,736 |
| 2023-09-12 | Esposito Pamela Chief Business Officer | Sale 10b5-1 | −300 | $20.00 | $6K | 263,436 |
| 2023-09-12 | Esposito Pamela Chief Business Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −300 | 86,033 | ||
| 2023-09-11 | Esposito Pamela Chief Business Officer | Option exercise 10b5-1 | +5,358 | $3.30 | $18K | 268,794 |
| 2023-09-11 | Esposito Pamela Chief Business Officer | Sale 10b5-1 | −5,358 | $20.01 | $107K | 263,436 |
| 2023-09-11 | Esposito Pamela Chief Business Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,358 | 86,333 |
Page 6 of 8 · 143 trades